Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

被引：0
|
作者：
Ali Afshar-Oromieh
Christian M. Zechmann
Anna Malcher
Matthias Eder
Michael Eisenhut
Heinz G. Linhart
Tim Holland-Letz
Boris A. Hadaschik
Frederik L. Giesel
Jürgen Debus
Uwe Haberkorn
机构：
[1] University Hospital of Heidelberg,Department of Nuclear Medicine
[2] German Cancer Research Centre,Department of Radiopharmaceutical Chemistry
[3] National Centre for Tumor Diseases (NCT)/DKFZ,Department of Biostatistics
[4] German Cancer Research Center,Department of Urology
[5] University Hospital of Heidelberg,Department of Radiation Oncology
[6] University Hospital of Heidelberg,Clinical Cooperation Unit Nuclear Medicine
[7] German Cancer Research Centre,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2014年 / 41卷
关键词：
Prostate cancer; PET/CT; Positron emission tomography; PSMA; Choline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 20
页数：9
相关论文
共 50 条
  • [21] Molecular imaging for prostate cancer: Performance analysis of 68Ga-PSMA PET/CT versus choline PET/CT
    Michaud, L.
    Touijer, K. A.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2017, 41 (05): : 292 - 299
  • [22] 68Ga-PSMA PET/CT in Staging and Restaging of prostate Cancer Patients: Comparative Study with 18F-Choline PET/CT
    Langsteger, W.
    Imamovic, L.
    Geinitz, H.
    Schiller, C.
    Moinfar, F.
    Rezaee, A.
    Pallwein-Prettner, L.
    Loidl, W.
    Beheshti, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S166 - S166
  • [23] 68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer
    Tatar, Gamze
    Ergul, Nurhan
    Baloglu, Mehmet Can
    Arslan, Esra
    Cermik, Tevfik Fikret
    [J]. CLINICAL NUCLEAR MEDICINE, 2023, 48 (03) : E135 - E137
  • [24] Comparison of 68Ga-PSMA PET/CT and 18F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall
    Soydal, Cigdem
    Demir, Burak
    Sutcu, Gizem
    Araz, Mine
    Kucuk, Nuriye Ozlem
    [J]. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2023, 32 (02) : 150 - 152
  • [25] 18F-CHOLINE PET/68Ga-PSMA PET SBRT in oligorecurrent prostate cancer: comparative analysis
    Mazzola, R.
    Napoli, G.
    Francolini, G.
    Triggiani, L.
    Nicosia, L.
    Figlia, V.
    Giaj-Levra, N.
    Ricchetti, F.
    Rigo, M.
    Cuccia, F.
    Livi, L.
    Magrini, S. M.
    Salgarello, M.
    Alongi, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S628 - S629
  • [26] Impact of 18F-PSMA-1007 Ligand PET/CT in Multimodal Imaging of Recurrent Prostate Cancer
    Dronka, L.
    Radzina, M.
    Tirane, M.
    Zemniece, L.
    Kalnina, M.
    Roznere, L.
    Lietuvietis, V.
    Freimanis, A.
    Vjaters, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S27 - S28
  • [27] 68Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer
    Henkenberens, Christoph
    von Klot, Christoph A.
    Ross, Tobias L.
    Bengel, Frank M.
    Wester, Hans-Juergen
    Merseburger, Axel S.
    Vogel-Claussen, Jens
    Christiansen, Hans
    Derlin, Thorsten
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (07) : 431 - 439
  • [28] Biodistribution of Ga-68 labelled PSMA ligand in normal tissues with PET/CT imaging
    Komek, H.
    Elboga, U.
    Can, C.
    Basibuyuk, M.
    Celen, Y.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S406 - S406
  • [29] F18-PSMA PET/CT in prostate cancer patients: frequency and distribution of benign findings and comparison to Ga68-PSMA imaging
    Kagna, Olga
    Khairulin, Maria
    Keidar, Zohar
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [30] COMPARISON OF 68Ga-PSMA PET-CT WITH CONVENTIONAL IMAGING IN LOCALIZATION OF BIOCHEMICAL RECURRENT PROSTATE CANCER
    Razmaria, Aria
    Calais, Jeremie
    Czernin, Johannes
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345